As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world.

Dr. Hoffarth explored the catalytic potential of the biosynthetic pathway of an antibiotic called indolmycin for contributions to natural product and antibiotic development. This exploration provided mechanistic insights for rare types of oxygen-dependent enzymes and produced novel derivatives of indolmycin using bacteria.

A randomly-selected Doctoral citation each day: today from the Doctor of Philosophy in Chemistry (PhD) - graduated in 2021